位置:首页 > 蛋白库 > K2C79_HUMAN
K2C79_HUMAN
ID   K2C79_HUMAN             Reviewed;         535 AA.
AC   Q5XKE5; Q6P465; Q7Z793;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   03-AUG-2022, entry version 145.
DE   RecName: Full=Keratin, type II cytoskeletal 79;
DE   AltName: Full=Cytokeratin-79;
DE            Short=CK-79;
DE   AltName: Full=Keratin-6-like;
DE            Short=Keratin-6L;
DE   AltName: Full=Keratin-79;
DE            Short=K79;
DE   AltName: Full=Type-II keratin Kb38;
GN   Name=KRT79; Synonyms=K6L, KB38, KRT6L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Skin;
RX   PubMed=15737194; DOI=10.1111/j.0022-202x.2004.23530.x;
RA   Rogers M.A., Edler L., Winter H., Langbein L., Beckmann I., Schweizer J.;
RT   "Characterization of new members of the human type II keratin gene family
RT   and a general evaluation of the keratin gene domain on chromosome
RT   12q13.13.";
RL   J. Invest. Dermatol. 124:536-544(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-81.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-81 AND LEU-195.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=11683385; DOI=10.1242/jcs.114.14.2569;
RA   Hesse M., Magin T.M., Weber K.;
RT   "Genes for intermediate filament proteins and the draft sequence of the
RT   human genome: novel keratin genes and a surprisingly high number of
RT   pseudogenes related to keratin genes 8 and 18.";
RL   J. Cell Sci. 114:2569-2575(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC   -!- INTERACTION:
CC       Q5XKE5; Q96CN4: EVI5L; NbExp=3; IntAct=EBI-2514135, EBI-749523;
CC       Q5XKE5; A1A4E9: KRT13; NbExp=3; IntAct=EBI-2514135, EBI-10171552;
CC       Q5XKE5; P02533: KRT14; NbExp=3; IntAct=EBI-2514135, EBI-702178;
CC       Q5XKE5; P19012: KRT15; NbExp=7; IntAct=EBI-2514135, EBI-739566;
CC       Q5XKE5; P08779: KRT16; NbExp=3; IntAct=EBI-2514135, EBI-356410;
CC       Q5XKE5; P05783: KRT18; NbExp=3; IntAct=EBI-2514135, EBI-297888;
CC       Q5XKE5; P08727: KRT19; NbExp=3; IntAct=EBI-2514135, EBI-742756;
CC       Q5XKE5; Q2M2I5: KRT24; NbExp=3; IntAct=EBI-2514135, EBI-2952736;
CC       Q5XKE5; Q7Z3Z0: KRT25; NbExp=3; IntAct=EBI-2514135, EBI-11980019;
CC       Q5XKE5; Q7Z3Y8: KRT27; NbExp=4; IntAct=EBI-2514135, EBI-3044087;
CC       Q5XKE5; Q7Z3Y7: KRT28; NbExp=3; IntAct=EBI-2514135, EBI-11980489;
CC       Q5XKE5; Q15323: KRT31; NbExp=6; IntAct=EBI-2514135, EBI-948001;
CC       Q5XKE5; Q14525: KRT33B; NbExp=8; IntAct=EBI-2514135, EBI-1049638;
CC       Q5XKE5; O76011: KRT34; NbExp=3; IntAct=EBI-2514135, EBI-1047093;
CC       Q5XKE5; Q92764: KRT35; NbExp=3; IntAct=EBI-2514135, EBI-1058674;
CC       Q5XKE5; O76013-2: KRT36; NbExp=3; IntAct=EBI-2514135, EBI-11958506;
CC       Q5XKE5; O76015: KRT38; NbExp=6; IntAct=EBI-2514135, EBI-1047263;
CC       Q5XKE5; A1L190: SYCE3; NbExp=3; IntAct=EBI-2514135, EBI-10283466;
CC       Q5XKE5; Q9BYV2: TRIM54; NbExp=3; IntAct=EBI-2514135, EBI-2130429;
CC       Q5XKE5; Q8N6Y0: USHBP1; NbExp=3; IntAct=EBI-2514135, EBI-739895;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, skin and scalp, but
CC       not in any other tissues or organs examined.
CC       {ECO:0000269|PubMed:15737194}.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin, I (acidic) and II (neutral to basic) (40-55 and 56-70 kDa,
CC       respectively).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ564105; CAD91893.1; -; mRNA.
DR   EMBL; AC107016; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96648.1; -; Genomic_DNA.
DR   EMBL; BC039148; AAH39148.1; -; mRNA.
DR   EMBL; BC063648; AAH63648.1; -; mRNA.
DR   EMBL; BK000976; DAA00403.1; -; Genomic_DNA.
DR   CCDS; CCDS8839.1; -.
DR   RefSeq; NP_787028.1; NM_175834.2.
DR   AlphaFoldDB; Q5XKE5; -.
DR   SMR; Q5XKE5; -.
DR   BioGRID; 130796; 48.
DR   IntAct; Q5XKE5; 31.
DR   MINT; Q5XKE5; -.
DR   STRING; 9606.ENSP00000328358; -.
DR   GlyGen; Q5XKE5; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q5XKE5; -.
DR   PhosphoSitePlus; Q5XKE5; -.
DR   SwissPalm; Q5XKE5; -.
DR   BioMuta; KRT79; -.
DR   DMDM; 296434550; -.
DR   EPD; Q5XKE5; -.
DR   jPOST; Q5XKE5; -.
DR   MassIVE; Q5XKE5; -.
DR   PaxDb; Q5XKE5; -.
DR   PeptideAtlas; Q5XKE5; -.
DR   PRIDE; Q5XKE5; -.
DR   ProteomicsDB; 65826; -.
DR   Antibodypedia; 26699; 119 antibodies from 16 providers.
DR   DNASU; 338785; -.
DR   Ensembl; ENST00000330553.6; ENSP00000328358.5; ENSG00000185640.6.
DR   GeneID; 338785; -.
DR   KEGG; hsa:338785; -.
DR   MANE-Select; ENST00000330553.6; ENSP00000328358.5; NM_175834.3; NP_787028.1.
DR   UCSC; uc001sbb.4; human.
DR   CTD; 338785; -.
DR   GeneCards; KRT79; -.
DR   HGNC; HGNC:28930; KRT79.
DR   HPA; ENSG00000185640; Tissue enriched (skin).
DR   MIM; 611160; gene.
DR   neXtProt; NX_Q5XKE5; -.
DR   OpenTargets; ENSG00000185640; -.
DR   PharmGKB; PA162393725; -.
DR   VEuPathDB; HostDB:ENSG00000185640; -.
DR   eggNOG; ENOG502SPJX; Eukaryota.
DR   GeneTree; ENSGT00940000161881; -.
DR   HOGENOM; CLU_012560_6_1_1; -.
DR   InParanoid; Q5XKE5; -.
DR   OMA; YMGQMDL; -.
DR   OrthoDB; 824246at2759; -.
DR   PhylomeDB; Q5XKE5; -.
DR   TreeFam; TF317854; -.
DR   PathwayCommons; Q5XKE5; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   SignaLink; Q5XKE5; -.
DR   BioGRID-ORCS; 338785; 24 hits in 1070 CRISPR screens.
DR   GeneWiki; KRT79; -.
DR   GenomeRNAi; 338785; -.
DR   Pharos; Q5XKE5; Tbio.
DR   PRO; PR:Q5XKE5; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q5XKE5; protein.
DR   Bgee; ENSG00000185640; Expressed in upper leg skin and 62 other tissues.
DR   ExpressionAtlas; Q5XKE5; baseline and differential.
DR   Genevisible; Q5XKE5; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045095; C:keratin filament; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030280; F:structural constituent of skin epidermis; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0031424; P:keratinization; IBA:GO_Central.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR032444; Keratin_2_head.
DR   InterPro; IPR003054; Keratin_II.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF16208; Keratin_2_head; 1.
DR   PRINTS; PR01276; TYPE2KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Intermediate filament; Keratin; Reference proteome.
FT   CHAIN           1..535
FT                   /note="Keratin, type II cytoskeletal 79"
FT                   /id="PRO_0000314893"
FT   DOMAIN          142..457
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..141
FT                   /note="Head"
FT   REGION          1..52
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..177
FT                   /note="Coil 1A"
FT   REGION          178..198
FT                   /note="Linker 1"
FT   REGION          199..290
FT                   /note="Coil 1B"
FT   REGION          291..314
FT                   /note="Linker 12"
FT   REGION          315..453
FT                   /note="Coil 2"
FT   REGION          454..535
FT                   /note="Tail"
FT   COMPBIAS        1..44
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            395
FT                   /note="Stutter"
FT   VARIANT         81
FT                   /note="L -> S (in dbSNP:rs2638497)"
FT                   /evidence="ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3"
FT                   /id="VAR_038113"
FT   VARIANT         195
FT                   /note="F -> L (in dbSNP:rs17855862)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_038114"
FT   VARIANT         266
FT                   /note="H -> R (in dbSNP:rs17688672)"
FT                   /id="VAR_038115"
FT   VARIANT         393
FT                   /note="A -> V (in dbSNP:rs17688627)"
FT                   /id="VAR_038116"
SQ   SEQUENCE   535 AA;  57836 MW;  B25A71327186A1C4 CRC64;
     MRSSVSRQTY STKGGFSSNS ASGGSGSQAR TSFSSVTVSR SSGSGGGAHC GPGTGGFGSR
     SLYNLGGHKS ISVSVAGGAL LGRALGGFGF GSRAFMGQGA GRQTFGPACP PGGIQEVTVN
     QSLLTPLHVE IDPEIQRVRT QEREQIKTLN NKFASFIDKV RFLEQQNKVL ETKWALLQEQ
     GQNLGVTRNN LEPLFEAYLG SMRSTLDRLQ SERGRLDSEL RNVQDLVEDF KNKYEDEINK
     HTAAENEFVV LKKDVDAAYM GRMDLHGKVG TLTQEIDFLQ QLYEMELSQV QTHVSNTNVV
     LSMDNNRNLD LDSIIAEVKA QYELIAQRSR AEAEAWYQTK YEELQVTAGK HGDNLRDTKN
     EIAELTRTIQ RLQGEADAAK KQCQQLQTAI AEAEQRGELA LKDAQKKLGD LDVALHQAKE
     DLTRLLRDYQ ELMNVKLALD VEIATYRKLL ESEESRMSGE CPSAVSISVT GNSTTVCGGG
     AASFGGGISL GGSGGATKGG FSTNVGYSTV KGGPVSAGTS ILRKTTTVKT SSQRY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025